Involvement of hnRNP A1 in the matrix metalloprotease-3-dependent regulation of Rac1 pre-mRNA splicing

Journal of Cellular Biochemistry

Volumn 113, Issue 7, 2012, Pages 2319-2329

  Pelisch, Federico ^a   Khauv, Davitte ^b   Risso, Guillermo ^a   Stallings Mann, Melody ^b   Blaustein, Matías ^a   Quadrana, Leandro ^a   Radisky, Derek C ^b   Srebrow, Anabella ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b MAYO CLINIC   (United States)

Author keywords

alternative splicing; hnrnp; matrix metalloprotease; Rac1

Indexed keywords

HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN; HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN A1; MESSENGER RNA; RAC1 PROTEIN; STROMELYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EXON; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; RNA SPLICING; SIGNAL TRANSDUCTION;

ALTERNATIVE SPLICING; ANIMALS; CELL LINE, TUMOR; EPITHELIAL CELLS; FEMALE; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN GROUP A-B; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; MATRIX METALLOPROTEINASE 3; MICE; NEUROPEPTIDES; PROTEIN ISOFORMS; PROTEOMICS; RAC GTP-BINDING PROTEINS; RNA PRECURSORS; RNA SPLICING; RNA, MESSENGER;

EID: 84861038625     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24103     Document Type: Article

References (61)

1. Biamonti G, Bassi MT, Cartegni L, Mechta F, Buvoli M, Cobianchi F, Riva S,. 1993. Human hnRNP protein A1 gene expression. Structural and functional characterization of the promoter. J Mol Biol 230: 77-89.
2. Black DL,. 2003. Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336.
3. Blanchette M, Chabot B,. 1999. Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J 18: 1939-1952.
4. Blaustein M, Pelisch F, Srebrow A,. 2007. Signals, pathways and splicing regulation. Int J Biochem Cell Biol 39: 2031-2048.
5. Brown RL, Reinke LM, Damerow MS, Perez D, Chodosh LA, Yang J, Cheng C,. 2011. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 121: 1064-1074.
6. Burd CG, Dreyfuss G,. 1994. RNA binding specificity of hnRNPA1: Significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing. EMBO J 13: 1197-1204.
7. Cammas A, Pileur F, Bonnal S, Lewis SM, Leveque N, Holcik M, Vagner S,. 2007. Cytoplasmic relocalization of heterogeneous nuclear ribonucleoprotein A1 controls translation initiation of specific mRNAs. Mol Biol Cell 18: 5048-5059.
8. Chabot B, Lebel C, Hutchison S, Nasim FH, Simard MJ,. 2003. Heterogeneous nuclear ribonucleoprotein particle A/B proteins and the control of alternative splicing of the mammalian heterogeneous nuclear ribonucleoprotein particle A1 pre-mRNA. Prog Mol Subcell Biol 31: 59-88.
9. Cheng C, Sharp PA,. 2006. Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion. Mol Cell Biol 26: 362-370.
10. Cheng C, Yaffe MB, Sharp PA,. 2006. A positive feedback loop couples Ras activation and CD44 alternative splicing. Genes Dev 20: 1715-1720.
11. David CJ, Manley JL,. 2010. Alternative pre-mRNA splicing regulation in cancer: Pathways and programs unhinged. Genes Dev 24: 2343-2364.
12. Del Gatto-Konczak F, Olive M, Gesnel MC, Breathnach R,. 1999. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer. Mol Cell Biol 19: 251-260.
13. Dreyfuss G, Kim VN, Kataoka N,. 2002. Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3: 195-205.
14. Dutertre M, Vagner S, Auboeuf D,. 2010. Alternative splicing and breast cancer. RNA Biol 7: 403-411.
15. Egeblad M, Werb Z,. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174.
16. Ghigna C, Moroni M, Porta C, Riva S, Biamonti G,. 1998. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res 58: 5818-5824.
17. Ghigna C, Giordano S, Shen H, Benvenuto F, Castiglioni F, Comoglio PM, Green MR, Riva S, Biamonti G,. 2005. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol Cell 20: 881-890.
18. Ghigna C, Valacca C, Biamonti G,. 2008. Alternative splicing and tumor progression. Curr Genomics 9: 556-570.
19. Goncalves V, Matos P, Jordan P,. 2009. Antagonistic SR proteins regulate alternative splicing of tumor-related Rac1b downstream of the PI3-kinase and Wnt pathways. Hum Mol Genet 18: 3696-3707.
20. Guil S, Caceres JF,. 2007. The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol 14: 591-596.
21. Guil S, Long JC, Cáceres JF,. 2006. hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol Cell Biol 26 (15): 5744-5758.
22. Izaurralde E, Jarmolowski A, Beisel C, Mattaj IW, Dreyfuss G, Fischer U,. 1997. A role for the M9 transport signal of hnRNP A1 in mRNA nuclear export. J Cell Biol 137: 27-35.
23. Jordan P, Brazao R, Boavida MG, Gespach C, Chastre E,. 1999. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene 18: 6835-6839.
24. Karni R, De Stanchina E, Lowe SW, Sinha R, Mu D, Krainer AR,. 2007. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat Struct Mol Biol 14: 185-193.
25. König H, Ponta H, Herrlich P,. 1998. Coupling of signal transduction to alternative pre-mRNA splicing by a composite splice regulator. EMBO J 1998; 17 (10): 2904-2913.
26. Labranche H, Dupuis S, Ben-David Y, Bani MR, Wellinger RJ, Chabot B,., 1998. Telomere elongation by hnRNP A1 and a derivative that interacts with telomeric repeats and telomerase. Nat Genet 19: 199-202.
27. Lewis SM, Veyrier A, Hosszu Ungureanu N, Bonnal S, Vagner S, Holcik M,. 2007. Subcellular relocalization of a trans-acting factor regulates XIAP IRES-dependent translation. Mol Biol Cell 18: 1302-1311.
28. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ,. 1997. Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 139: 1861-1872.
29. Lochter A, Sternlicht MD, Werb Z, Bissell MJ,. 1998. The significance of matrix metalloproteinases during early stages of tumor progression. Ann N Y Acad Sci 857: 180-193.
30. Matlin AJ, Clark F, Smith CW,. 2005. Understanding alternative splicing: Towards a cellular code. Nat Rev Mol Cell Biol 6: 386-398.
31. Matos P, Jordan P,. 2008. Increased Rac1b expression sustains colorectal tumor cell survival. Mol Cancer Res 6: 1178-1184.
32. Matos P, Collard JG, Jordan P,. 2003. Tumor-related alternatively spliced Rac1b is not regulated by Rho-GDP dissociation inhibitors and exhibits selective downstream signaling. J Biol Chem 278: 50442-50448.
33. Matos P, Oliveira C, Velho S, Goncalves V, Da Costa LT, Moyer MP, Seruca R, Jordan P,. 2008. B-Raf(V600E) cooperates with alternative spliced Rac1b to sustain colorectal cancer cell survival. Gastroenterology 135: 899-906.
34. Michlewski G, Guil S, Caceres JF,. 2011. Stimulation of pri-miR-18a Processing by hnRNP A1. Adv Exp Med Biol 700: 28-35.
35. Moran-Jones K, Grindlay J, Jones M, Smith R, Norman JC,. 2009. hnRNP A2 regulates alternative mRNA splicing of TP53INP2 to control invasive cell migration. Cancer Res 69: 9219-9227.
36. Nelson CM, Khauv D, Bissell MJ, Radisky DC,. 2008. Change in cell shape is required for matrix metalloproteinase-induced epithelial-mesenchymal transition of mammary epithelial cells. J Cell Biochem 105: 25-33.
37. Nilsen TW, Graveley BR,. 2010. Expansion of the eukaryotic proteome by alternative splicing. Nature 463: 457-463.
38. Orlichenko L, Geyer R, Yanagisawa M, Khauv D, Radisky ES, Anastasiadis PZ, Radisky DC,. 2010. The 19-amino acid insertion in the tumor-associated splice isoform Rac1b confers specific binding to p120 catenin. J Biol Chem 285: 19153-19161.
39. Patry C, Bouchard L, Labrecque P, Gendron D, Lemieux B, Toutant J, Lapointe E, Wellinger R, Chabot B,. 2003. Small interfering RNA-mediated reduction in heterogeneous nuclear ribonucleoparticule A1/A2 proteins induces apoptosis in human cancer cells but not in normal mortal cell lines. Cancer Res 63: 7679-7688.
40. Pinol-Roma S, Dreyfuss G,. 1992. Shuttling of pre-mRNA binding proteins between nucleus and cytoplasm. Nature 355: 730-732.
41. Radisky ES, Radisky DC,. 2010. Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15: 201-212.
42. Radisky DC, Levy DD, Littlepage LE, Liu H, Nelson CM, Fata JE, Leake D, Godden EL, Albertson DG, Nieto MA, Werb Z, Bissell MJ,. 2005. Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability. Nature 436: 123-127.
43. Rothrock CR, House AE, Lynch KW,. 2005. HnRNP L represses exon splicing via a regulated exonic splicing silencer. EMBO J 24: 2792-2802.
44. Schnelzer A, Prechtel D, Knaus U, Dehne K, Gerhard M, Graeff H, Harbeck N, Schmitt M, Lengyel E,. 2000. Rac1 in human breast cancer: Overexpression, mutation analysis, and characterization of a new isoform, Rac1b. Oncogene 19: 3013-3020.
45. Shapiro IM, Cheng AW, Flytzanis NC, Balsamo M, Condeelis JS, Oktay MH, Burge CB, Gertler FB,. 2011. An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet 7: e1002218.
46. Singh A, Karnoub AE, Palmby TR, Lengyel E, Sondek J, Der CJ,. 2004. Rac1b, a tumor associated, constitutively active Rac1 splice variant, promotes cellular transformation. Oncogene 23: 9369-9380.
47. Skotheim RI, Nees M,. 2007. Alternative splicing in cancer: Noise, functional, or systematic ? Int J Biochem Cell Biol 39: 1432-1449.
48. Srebrow A, Kornblihtt AR,. 2006. The connection between splicing and cancer. J Cell Sci 119: 2635-2641.
49. Stallings-Mann M, Radisky D,. 2007. Matrix metalloproteinase-induced malignancy in mammary epithelial cells. Cells Tissues Organs 185: 104-110.
50. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z,. 1999. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 98: 137-146.
51. Sternlicht MD, Bissell MJ, Werb Z,. 2000. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter. Oncogene 19: 1102-1113.
52. Stickeler E, Kittrell F, Medina D, Berget SM,. 1999. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18: 3574-3582.
53. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z,. 1994. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 125: 681-693.
54. Thiery JP, Sleeman JP,. 2006. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142.
55. Valacca C, Bonomi S, Buratti E, Pedrotti S, Baralle FE, Sette C, Ghigna C, Biamonti G,. 2010. Sam68 regulates EMT through alternative splicing-activated nonsense-mediated mRNA decay of the SF2/ASF proto-oncogene. J Cell Biol 191: 87-99.
56. Van Der Houven Van Oordt W, Diaz-Meco MT, Lozano J, Krainer AR, Moscat J, Caceres JF,. 2000. The MKK(3/6)-p38-signaling cascade alters the subcellular distribution of hnRNP A1 and modulates alternative splicing regulation. J Cell Biol 149: 307-316.
57. Venables JP,. 2004. Aberrant and alternative splicing in cancer. Cancer Res 64: 7647-7654.
58. Venables JP,. 2006. Unbalanced alternative splicing and its significance in cancer. Bioessays 28: 378-386.
59. Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP,. 2009. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell 33: 591-601.
60. Zerbe LK, Pino I, Pio R, Cosper PF, Dwyer-Nield LD, Meyer AM, Port JD, Montuenga LM, Malkinson AM,. 2004. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: Implications for pre-mRNA processing. Mol Carcinog 41: 187-196.
61. Zhang QS, Manche L, Xu RM, Krainer AR,. 2006. hnRNP A1 associates with telomere ends and stimulates telomerase activity. RNA 12: 1116-1128.